Key Board Member Resigns from Jupiter Neurosciences Amidst Financial Distress
JUNS sits 35% above its 52-week low of $0.172 on light trading volume (0.2× avg).
Summary
Allison W. Brady has resigned from Jupiter Neurosciences' Board of Directors and its Audit and Compensation Committees, effective June 17, 2026. This departure adds to governance concerns for a micro-cap company already facing severe financial distress, including 'going concern' warnings and Nasdaq delisting threats. While the company stated no disagreement, the loss of a board member from key oversight committees creates further instability. The board seat will remain vacant until the annual meeting on July 22, 2026, where a reverse stock split is also up for shareholder approval.
At the time of this announcement, JUNS was trading at $0.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.5M. The 52-week trading range was $0.17 to $3.33. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.